Language
Branch
Start Your Career
Industry

Consulting for Pharmaceutical Manufacturers: GMP Compliance from Development to Production.

The pharmaceutical industry is under enormous pressure: stricter GMP requirements (Annex 1), fragile supply chains, and the need for digitalization. ENTOURAGE supports pharmaceutical companies from drug discovery through to GDP-compliant distribution. With over 200 specialized consultants in Germany, Switzerland, and Italy.

Pharmaceutical Manufacturing and GMP Compliance: Consulting for Pharmaceutical Manufacturers
+500
Successful pharmaceutical and biotech projects worldwide
100%

's Audit Success Rate for FDA and EMA Inspections
Top 10
Leading pharmaceutical companies
rely on our expertise
When Is Consulting Critical to Success for Pharmaceutical Manufacturers?
In the pharmaceutical industry, compliance is inextricably linked to supply security. Consulting services for pharmaceutical manufacturers help companies implement complex GxP requirements—such as sterile manufacturing in accordance with EU GMP Annex 1—in a process-integrated and scalable manner. From computer system validation (CSV according to GAMP 5) to qualification programs and technology transfers (Tech Transfer & Scale-up) to preparation for critical FDA or EMA inspections (Inspection Readiness): Specialized consulting translates regulatory restrictions into efficient, audited operational processes.

What challenges will shape the pharmaceutical industry in 2026?

The life sciences industry is undergoing the most profound regulatory changes in decades. For pharmaceutical manufacturers, this results in concrete operational bottlenecks:

  • EU GMP Annex 1 (2023) requires new contamination control strategies (CCS) in sterile manufacturing—many sites are not prepared
  • Supply chain bottlenecks involving critical active pharmaceutical ingredients (APIs) and primary packaging materials are jeopardizing supply security
  • The FDA and EMA are tightening requirements for data integrity (ALCOA+) and 21 CFR Part 11 for computerized systems
  • The scale-up of ATMPs (Advanced Therapy Medicinal Products) and biologics poses new challenges for traditional production infrastructures
  • A shortage of skilled workers in specialized GxP roles (Qualified Persons, CSV experts, Regulatory Affairs) is slowing down projects
  • GDP (Good Distribution Practice) compliance is becoming a core operational competency for temperature-sensitive biologics
"The biggest challenge for pharmaceutical companies isn't the regulatory framework itself, but integrating compliance into existing operational processes without delaying time-to-market. Those who seek out specialized expertise early on end up saving months and millions."
– Dr. Nils Sunder-Plassmann, Vice President of Pharmaceuticals, ENTOURAGE
Pharmaceutical consulting services: GMP, supply chain, and regulatory affairs

Our pharmaceutical consulting services.

We combine in-depth regulatory expertise with operational excellence to provide comprehensive support to pharmaceutical companies.

GMP Compliance & Annex 1
Development and implementation of Contamination Control Strategies (CCS), gap analyses of existing facilities, support during GMP inspections (EMA, FDA), and mock audit programs to ensure inspection readiness.
→ Learn more about Annex 1 consulting
Supply Chain & GDP
GDP-compliant distribution strategies, cold chain validation for biologics, supplier qualification, dual-source strategies, and supply chain governance frameworks.
Production Transfer & Scale-up
Management of end-to-end technology transfer projects from the laboratory to commercial production. Process validation (PPQ), batch record preparation, and CMC documentation.
CSV & Data Integrity
Computer System Validation (GAMP 5) for MES, LIMS, and ERP. ALCOA+ gap assessments, 21 CFR Part 11 compliance, and audit trail reviews.
Regulatory Affairs & Marketing Authorization
Regulatory strategies (EU, FDA, Swissmedic), post-market surveillance, variation management, and interactions with health authorities for pharmaceuticals and biologics.
Lean Manufacturing & Operational Excellence
Improving efficiency in pharmaceutical manufacturing through lean methods, shop floor management, and continuous improvement programs in a GMP environment.

Our expertise in the pharmaceutical industry.

ENTOURAGE covers the entire pharmaceutical lifecycle through six specialized clusters of expertise—from research to distribution.

Cluster 1

Regulatory & Compliance

Regulatory strategies (EMA, FDA, Swissmedic), post-market surveillance, variation management, and inspection readiness for pharmaceuticals.

GMP · Annex 1 · FDA · ATMPs · Health Authority Cluster 2

Quality Management

GMP-compliant quality management systems, CAPA and deviation management, process validation, cleanroom qualification, and continuous improvement.

CAPA · Deviations · ISO 9001 · GLP · Lean Six Sigma Cluster 3

Clinical and Medical Affairs

Clinical trials (Phases I–IV), GCP monitoring, pharmacovigilance, signal detection, CMC consulting, and QPPV services.

GCP · CRO · Pharmacovigilance · CMC · PMCF Cluster 4

R&D & Engineering

Feasibility studies, prototyping, design controls, verification and validation, and biocompatibility studies for pharmaceutical products.

V&V · Feasibility · Biocompatibility · Prototyping Cluster 5

Manufacturing & Supply Chain

CAPEX Consulting, Lean Manufacturing, Technology Transfer & Scale-up, GDP, Supplier Qualification, and Supply Chain Governance.

CAPEX · GDP · Lean · Scale-up · Procurement Cluster 6

Business Data Solutions & IT

Computer System Validation (CSV/GAMP 5), Data Integrity (ALCOA+), ERP Implementation, IT Audits, and Digital Governance.

CSV · ALCOA+ · Part 11 · ERP · ISO 27001

Why pharmaceutical companies work with ENTOURAGE.

What sets us apart from traditional management consultancies and individual consultants:

ENTOURAGE Major consulting projects Freelancer
Industry Focus 100% Life Sciences Across all industries A single niche
Implementation On-site operations More of a strategic move Hands-on, individual
Team size 200+ consultants, scalable Large teams available individual
Level of regulation GxP, FDA, EMA, ICH Generalist In a niche of its own
Flexibility Project contract or framework agreement Long contract terms Daily

Successful pharmaceutical projects.

Our case studies demonstrate how ENTOURAGE supports pharmaceutical companies in process optimization and regulatory compliance.

Audit readiness in six weeks at a growing CDMO
Challenge: A growing CDMO was about to undergo its first EMA inspection but had only a rudimentary quality system in place, lacking clear responsibilities and SOP structures.

Actions: Strategic overall QMS planning, on-site development of operational SOPs, training, and mock audits. Implementation of a CAPA and audit tracking tool.

Result: EMA inspection passed without any non-conformities. Reduction of SOP review times by 35%.
Passed FDA re-inspection with CAPA and mock audit
Challenge: A pharmaceutical manufacturer had received several 483 observations during an FDA inspection and had to pass the re-inspection within four months.

Actions: Root cause analysis of all observations, development of a CAPA plan, process optimization in sterile production, two mock inspections.

Result: Passed the FDA re-inspection without any new observations. CAPA closure rate of 100%.
Regulatory strategy for an innovative combination product
Challenge: A pharmaceutical company developed a drug-device combination product and needed a regulatory strategy for the EU and the U.S.

Actions: Regulatory classification and strategy development, coordination between CMC, clinical, and device teams, pre-submission meetings with the FDA, and scientific advice from the EMA.

Result: Clear regulatory roadmap. Reduction of the expected approval time by 8 months. Successful pre-submission interaction with the FDA.

Frequently Asked Questions About Consulting Services for Pharmaceutical Manufacturers.

What pharmaceutical regulations does Entourage cover?
We provide global support for compliance with the requirements of the EMA, FDA, Swissmedic, and national authorities. Our areas of expertise include EU GMP (including Annex 1), GDP, GLP, GCP, 21 CFR Part 11, and industry-specific ISO standards. Our consultants have an average of 10+ years of regulatory experience.
Does Entourage also support ATMPs and biologics?
Yes, we have specialized teams for Advanced Therapy Medicinal Products (ATMPs) and biologics. We support you every step of the way, from CMC consulting and clinical evaluation through to successful scale-up and commercial approval—including facility design and process validation.
How does Entourage prepare for GMP inspections?
With our “Inspection Readiness” services and mock audits, we ensure your teams and processes are fully prepared for inspections by the EMA, FDA, or national regulatory authorities. We conduct gap analyses, develop remediation plans, and coach your staff in preparation for the audit.
What sets Entourage apart from traditional management consulting firms?
ENTOURAGE is not a traditional strategy consulting firm. Our consultants are trained scientists, engineers, and regulatory affairs experts who work directly on your projects—from the shop floor to regulatory submissions. We don’t just make recommendations; we put them into action.
Can ENTOURAGE provide support with international pharmaceutical approvals?
Yes. We provide support for regulatory approval processes with the EMA, FDA, Swissmedic, PMDA (Japan), and other regulatory agencies. Our regulatory affairs experts assist with regulatory strategies, interactions with health authorities, scientific advice meetings, and the preparation of regulatory dossiers for drugs, biologics, and combination products.
How quickly can ENTOURAGE provide a Qualified Person on demand?
Typically within 2–4 weeks. Our Qualified Persons (QPs) are licensed pharmacists with many years of GMP experience and expertise in accordance with Section 15 of the German Medicines Act (AMG). We offer flexible models: from project-based QP support to long-term staffing.
What experience does ENTOURAGE have with pharmaceutical production transfer and scale-up?
We have supported over 50 technology transfer projects, ranging from laboratory scale to commercial GMP production. Our experts provide support for process validation (PPQ), batch record preparation, analytical transfer, and CMC documentation. We place a particular focus on biologics and sterile dosage forms.

Your contacts for the pharmaceutical industry.

Talk directly to our industry experts—we’ll connect you with the right team.

Dr. Nils sunder-plassmann
Dr. Nils Sunder-Plassmann
Vice President Pharma

Strategic consulting and project management for pharmaceutical clients in the areas of GMP, regulatory affairs, and supply chain.

Connect on LinkedIn
Andreas weirich
Andreas Weirich
Head of Pharma Sales

Your first point of contact for project inquiries, framework agreements, and customized consulting packages in the pharmaceutical sector.

Connect on LinkedIn

Other industries.

Industry

MedTech

EU MDR, design controls, usability engineering, and post-market surveillance for medical devices.

 Industry

Biotechnology

Scale-up of biologics, CMC consulting, GMP for ATMPs, and clinical development strategies.

 Industry

In Vitro Diagnostics (IVD)

IVDR Transition, Performance Studies, Performance Evaluation, and CE Marking for Diagnostics.

Talk to our pharmaceutical experts.

Whether it's GMP compliance, technology transfer, or regulatory approval—we'll find the right solution for your project.

Ensuring project success in the pharmaceutical industry.

Tell us about your regulatory or operational challenge, and we’ll provide you with a tailored proposal for your pharmaceutical project within 24 hours.